Filter
772
Text search:
Beta
Featured
Recommendations
92
New Publications
141
Language
Document type
No document type
280
Guidelines
210
Studies & Reports
169
Manuals
41
Fact sheets
34
Strategic & Response Plan
18
Situation Updates
8
Training Material
5
Resource Platforms
3
Infographics
3
Brochures
1
Countries / Regions
India
56
Global
40
South Africa
25
Indonesia
21
Brazil
21
Latin America and the Carribbean
19
Kenya
18
Africa
18
Ethiopia
16
Philippines
13
Germany
12
Nepal
10
Ghana
8
Tanzania
7
Western and Central Europe
7
Paraguay
7
Argentina
6
Venezuela
6
Nigeria
5
Uganda
5
Rwanda
5
Malawi
5
Mozambique
5
Ukraine
5
Colombia
5
Zimbabwe
4
Peru
4
Ecuador
4
Bolivia
4
Sierra Leone
3
Cameroon
3
Pakistan
3
Bangladesh
3
Namibia
3
Eswatini/ Swaziland
3
Angola
3
Chile
3
East and Southern Africa
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Russia
3
Spain
3
Burkina Faso
2
Liberia
2
Congo, Democratic Republic of
2
South Sudan
2
Zambia
2
Papua New Guinea
2
North Macedonia
2
El Salvador
2
Libya
2
Lesotho
2
Myanmar / Burma
2
Western Pacific Region
2
Armenia
2
Kyrgyzstan
2
Kazakhstan
2
Georgia
2
Vietnam
2
Belarus
2
Senegal
1
Mali
1
Guinea-Bissau
1
USA
1
Saudi Arabia
1
Jordan
1
Afghanistan
1
Egypt
1
Chad
1
Cambodia
1
Thailand
1
Benin
1
Central African Republic
1
Serbia
1
Honduras
1
Botswana
1
Madagascar
1
South–East Asia Region
1
Fiji
1
Bhutan
1
Eastern Europe
1
Italy
1
Mongolia
1
Laos
1
Tajikistan
1
Uzbekistan
1
Gabon
1
Uruguay
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
317
Clinical Guidelines
78
Public Health
56
Women & Child Health
20
Key Resources
10
Pharmacy & Technologies
9
Capacity Building
1
Toolboxes
AMR
134
COVID-19
113
NCDs
66
Mental Health
56
Pharmacy
38
Planetary Health
23
HIV
17
Specific Hazards
16
TB
13
Caregiver
13
NTDs
10
Conflict
8
Global Health Education
7
Refugee
5
Ebola & Marburg
4
Natural Hazards
4
Rapid Response
4
Health Financing Toolbox
4
Disability
2
Cholera
2
2.0 Rapid Response
2
Zika
1
Malaria
1
A new Ebola crisis page that provides an overview of the data available in HDX. The page includes an interactive map of the worst-affected countries, the top-line figures for the crisis, a graph of cumulative Ebola cases and deaths, and over 40 datasets. Go to the website link https://data.hdx.rwlab
...
The Climate Change Knowledge Portal (CCKP) Beta is a central hub of information, data and reports about climate change around the world. Here you can query, map, compare, chart and summarize key climate and climate-related information.
Los coronavirus son un grupo de virus ARN altamente diversos de la familia Coronaviridae que se dividen en
4 géneros: alfa, beta, gamma y delta, y que causan enfermedades de leves a graves en humanos y animales
(1-3). Existen coronavirus humanos
...
Several challenges face asthma management in Egypt, including the high percentage of uncontrolled patients, inadequate compliance, and overuse of short-acting beta-agonists (SABAs) leading to increased asthma-related morbidity and mortality. In this
...
Zambia has recognised the Public Health threat of antimicrobial resistance and its impact on morbidity and mortality, as well as the subsequent economic consequences. The country has recorded microorganisms which have developed resistance to antimicrobial drugs. Notable among these are; Multidrug Re
...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t
...
Injury to the skin and underlying tissues from acute exposure to
a large external dose of radiation is referred to as cutaneous
radiation injury (CRI). Acute radiation syndrome (ARS) 1 will
usually be accompanied by some skin damage; however, CRI
can
...
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly
...
Over 90% of the morbidity and mortality related to chronic obstructive pulmonary disease (COPD) and asthma occurs in low-income and middle-income countries (LMICs) due to well documented factors including decreased access to screening, trained health professionals, and therapies for disease manageme
...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support
...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati
...
This short paper aims to identify key evidence gaps in our knowledge of livestock- and fisheries-linked antimicrobial resistance in the developing world, and to document on-going or planned research initiatives on this topic by key stakeholders.
The antimicrobial resistant (AMR) infections in anima
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
Background
Asthma remains highly prevalent, with more severe symptoms in low-income to middle-income countries (LMICs) compared with high-income countries. Identifying risk factors for severe asthma symptoms can assist with improving outcomes. We aimed to determine the prevalence, severity and ris
...
Weekly epidemiological update on COVID-19, 28 September 2022
Poster, 4 Janaury 2022
Remdesivir for COVID-19
recommended
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
5 Ways Hospital Pharmacists Can Be Antibiotics Aware - Poster
This action plan for the Kingdom Saudi Arabia to combat antimicrobial resistance has been formulated in the line of the WHO five objectives. It addresses the need for effective “one health” approach involving coordination among numerous national sectors and actors, including human and veterinary
...
